对于未经纠正的前庭隔膜缺陷的青少年进行改性电治疗的麻醉考虑:一个案例报告
Vikash Bansal1, Kausiki Poddar1, Sanjay Kumar1
1Anaesthesiology, Critical Care and Pain Medicine, All India Institute of Medical Sciences, Deoghar, IND.
Cureus
|December 16, 2024
概括
电疗法 (ECT) 是一种安全的治疗方法,即使在未经纠正的心房缺陷 (ASD) 患者中. 本案例研究表明,在一个患有猫和自闭症的年轻男性中,ECT的成功应用.
科学领域:
- 神经科学是一个神经科学.
- 心脏病学 心脏病学
- 麻醉学 麻醉学
背景情况:
- 卡塔托尼亚是一种严重的神经精神疾病,可以通过电疗法 (ECT) 有效管理.
- 电磁心电有心血管风险,特别是在患有先前心脏病的患者中,使其在先天性心脏病中的使用具有争议.
- 由于潜在的血液动力学不稳定性,未被纠正的心房 Septal 缺陷 (ASD) 呈现出 ECT 管理的高风险概况.
研究的目的:
- 评估修改后的ECT在患有白内障和未经纠正的心房 Septal 缺陷 (ASD) 的患者的安全性和有效性.
- 要突出麻醉方面的考虑,管理患有先天性心脏病的患者接受ECT.
- 强调在管理复杂的精神病和心脏病例时采用多学科方法的重要性.
主要方法:
- 一个18岁的男性病例报告,因未经纠正的ASD而患有猫和持续的沉默症.
- 患者在麻醉和肌肉放松下接受了六次修改后的ECT循环.
- 麻醉治疗的重点是保持肺血管抵抗力,略微减少全身血管抵抗力.
主要成果:
- 患者成功完成了六个周期的修改ECT,没有显著的心血管并发症.
- 该程序被很好地容忍,证明了ECT在这个高风险患者群体中的可行性.
- 该案例强调了多学科团队方法的成功应用.
结论:
- 修改后的ECT可以安全地给患有白内障和未经纠正的心房 Septal 缺陷 (ASD) 的患者使用.
- 谨慎的麻醉管理对于在患有先天性心脏病的患者在ECT期间保持血液动力稳定至关重要.
- 这个案例支持在某些患有复杂心脏病的患者中使用ECT,这需要一个协作的团队努力.
更多相关视频
04:51Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
Published on: April 11, 2019
9.3K
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
12.0K
相关概念视频
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
